medical-devices is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention AtriCure, the most common co-covered peer. The tracked stories average 2 original sources each. Isolator Synergy Clamps appears in 1 tracked Healthcare story from September 13, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Isolator Synergy Clamps
medical-devices is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention AtriCure, the most common co-covered peer. The tracked stories average 2 original sources each. Isolator Synergy Clamps appears in 1 tracked Healthcare story from September 13, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 6 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Isolator Synergy Clamps. Shared-story counts are live from our verified record — not editorial picks.
AtriCure CTO Salvatore Privitera sold $201,135 in shares under a prearranged 10b5-1 plan while retaining $7.9 million in equity. The sale is routine for medtech executives, shifting focus to AtriCure's cardiac ablation portfolio and hospital adoption.
Isolator Synergy Clamps is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.